National Institute Of Cardiology, Warsaw, Poland

This study tests whether empagliflozin, a drug typically used for diabetes, can help people with hypertrophic cardiomyopathy (a thickened heart muscle) who do not have diabetes. Over 12 months, 250 adults will receive either the drug or a placebo to see if it improves their exerc…